🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hello everyone, this is the official twitter account of PulmoBioMed.com. We will use this channel to discuss all things breath, and present our latest findings. Join us in the journey to making Your Breath, the Window to Your Health (TM).

Our Pre-print on exhaled breath detection of COVID-19 and bacteria from your lung. TL;DR summary: you do not emit any virus if you are infected, have symptoms, and are breathing in a relaxed fashion. This DOES NOT mean COVID-19 isn’t airborne 1/n medrxiv.org/content/10.110…

100% detection of SARS-CoV-2 genomes in 1 min of forced exhaled breath. PBM-HALE is the only device that yields deep lung fine aerosols devoid of upper respiratory or oral matter. Read our science on medRxiv medrxiv.org/content/10.110…

Our Early Access Programme is now live - but capacity is very limited. Get in touch to find out how sampling aerosols from the distal airways, entirely saliva-free, can help you understand lung disease. #IPF #cysticfibrosis #COPD #asthma #wheeze #health pulmobiomed.com/early-access-p…

We are delighted to announce that PulmoBioMed Ltd. has been selected as a region winner of the TechNation 5.0 Rising Stars competition after hundreds of entries nationally!

Great to see PulmoBioMed win the region #TechNation Rising Stars competition!

Follow our North East City Winners and Partners: SportFin Mercia Asset Management PLC Grid Finder | Sim Racing Leagues @HumanWisdom_me PulmoBioMed Fundify Global Teacher Reveela @SaferDate Vibbl

🫁 PulmoBioMed is making exhaled breath diagnostics a clinical reality.

PulmoBioMed develops AI-based technology and product design for a medical device to capture and analyze exhaled breath. Exhaled breath contains a wealth of biomarkers that can detect and be used to monitor over 40 disease states.

We are over the moon! PulmoBioMed has won the regional TechNation Rising Stars competition and have made it to the National semi finals to be held next week. Exciting days coming, and more news soon on the data power offered by PBM-HALE!

PulmoBioMed develops AI-based technology and product design for a medical device to capture and analyze exhaled breath. Exhaled breath contains a wealth of biomarkers that can detect and be used to monitor over 40 disease states.

Huge congratulations to Northumbria #medtech spinout PulmoBioMed who are national finalists in Tech Nation's Rising Stars competition! Northern Accelerator #TakeOnTomorrow #Research #Innovation

We are delighted to announce that we have made it to the national finals of the V5 TechNation Rising stars competition- the top 4% of all applicants this year!

Having trouble accessing PulmoBioMed.com? So do we! Google has sold it's domain business to @Squarespace and that's broken the link of the domain (now registered with squarespace) to our page (also hosted by squarespace!). You can reach it at pulmobiomed.squarespace.com

It's conference season and hot off the back of ESCMID2024 and ATS2024 we're at #MicroAerosols24 presenting the outcome of our distal lung aerosol clinical studies.